These drugs are new to us, but theyve been at least a decade in development for diabetes, says Katrina Bicknell, professor of pharmacology and pharmacy education at Reading School of Pharmacy
Additional risk factors relate to compounding quality: API source, sterility, potency consistency, and absence of FDA pre-market review of the specific formulation
Most people dont take medication for the side effects.But some Americans are turning to a group of diabetes medications for something other than relief from the disease
A thorough assessment of your body contouring goals and medical suitability, with honest guidance on what results to expect and how many sessions are likely needed
Instead of distinguishing between the two, the agency is recommending that the labeling for both follow-ons include a biosimilarity statement. Read More First Circuit gives MDL win to GSK Citing federal preemption, the U.S